9-37512715-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012166.3(FBXO10):c.2703T>A(p.Asp901Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000332 in 1,613,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012166.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO10 | NM_012166.3 | c.2703T>A | p.Asp901Glu | missense_variant | 11/11 | ENST00000432825.7 | NP_036298.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO10 | ENST00000432825.7 | c.2703T>A | p.Asp901Glu | missense_variant | 11/11 | 1 | NM_012166.3 | ENSP00000403802 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000304 AC: 75AN: 246614Hom.: 0 AF XY: 0.000299 AC XY: 40AN XY: 133960
GnomAD4 exome AF: 0.000342 AC: 500AN: 1461156Hom.: 0 Cov.: 30 AF XY: 0.000312 AC XY: 227AN XY: 726824
GnomAD4 genome AF: 0.000230 AC: 35AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.2703T>A (p.D901E) alteration is located in exon 11 (coding exon 10) of the FBXO10 gene. This alteration results from a T to A substitution at nucleotide position 2703, causing the aspartic acid (D) at amino acid position 901 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at